Keum Young Ahn (KeumYoung Ahn, Keumyoung Ahn)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Ankylosing Spondylitis

Respiratory Syndrome Coronavirus

Clinical Practice

Top Venues

Expert opinion on biological therapy

Emerging microbes & infections

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Infectious diseases and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy 24 (4) (2024)
Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy 24 (4) (2024)
Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy 24 (4) (2024)
Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy (2024)
Jae-Cheol Jo, Youngwoo Jean, DaJung Kim, Deok-Hwan Yang, Won Sik Lee, Yoon Seok Choi, Jun Ho Yi, Dok Hyun Yoon, Jee Hyun Kong, Jung-Yoon Choe, Sung Hyun Kim, Keum Young Ahn, TaeHong Park, Hana Ju, Soonbum Kwon, Seok-Goo Cho
A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea. Expert opinion on biological therapy (2023)
Jae-Cheol Jo, Young-Woo Jeon, Da Jung Kim, Deok-Hwan Yang, Won Sik Lee, Yoon Seok Choi, Jun Ho Yi, Dok Hyun Yoon, Jee Hyun Kong, Jung-Yoon Choe, SungHyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Soonbum Kwon, Seok-Goo Cho
A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea. Expert opinion on biological therapy (2023)
Justin Stebbing, Yauheni Baranau, Valery Baryash, Vladimir Moiseyenko, Dmytro Boliukh, Nicoleta Antone, Alexey Manikhas, Anatolii Chornobai, Tae Hong Park, Eric Hyungseok Baek, Jaeyong Lee, Jiin Choi, Nahyun Kim, Keum Young Ahn, Sang Joon Lee, Sunghyun Kim
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Ji Yeon Lee, Seon Hee Bu, EunHyang Song, Seongcheol Cho, Sungbong Yu, Jungok Kim, Sungmin Kim, Kwang Won Seo, Ki Tae Kwon, Jin Yong Kim, Sung Hyun Kim, Keum Young Ahn, Nahyun Jung, Yeonmi Lee, Yoobin Jung, Chankyoung Hwang, Wan Beom Park
Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea. Infectious diseases and therapy (2023)
Ji-Min Seo, Bobin Kang, Rina Song, Hanmi Noh, Cheolmin Kim, Jong-In Kim, Minsoo Kim, Dong-Kyun Ryu, Min-Ho Lee, Jeong-Sun Yang, Kyung-Chang Kim, Joo-Yeon Lee, Hansaem Lee, Hye-Min Woo, Jun-Won Kim, Jung-Ah Choi, Man Ki Song, Monika Tomaszewska-Kiecana, Anna Wołowik, Agnieszka Kulesza, Sung Hyun Kim, Keum Young Ahn, Nahyun Jung, Soo-Young Lee
Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Emerging microbes & infections 11 (1) (2022)